Credit Suisse Ag Spring Works Therapeutics, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 59,198 shares of SWTX stock, worth $2.78 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

59,198

Previous 37,019 59.91%

Holding current value

$2.78 Million

Previous $1.35 Million 115.62%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$36.5 - $52.5 $809,533 - $1.16 Million	22,179 Added 59.91%	59,198 $2.91 Million
Q4 2023 Feb 08, 2024	BUY	$18.94 - $37.24 $67,975 - $133,654	3,589 Added 10.74%	37,019 $1.35 Million
Q3 2023 Nov 13, 2023	SELL	$23.12 - $31.38 $281,786 - $382,459	-12,188 Reduced 26.72%	33,430 $772,000
Q2 2023 Aug 11, 2023	BUY	$23.15 - $32.71 $309,723 - $437,627	13,379 Added 41.5%	45,618 $1.2 Million
Q1 2023 May 10, 2023	BUY	$24.97 - $34.05 $217,313 - $296,337	8,703 Added 36.98%	32,239 $829,000
Q4 2022 Feb 13, 2023	SELL	$21.73 - $28.72 $51,978 - $68,698	-2,392 Reduced 9.23%	23,536 $612,000
Q3 2022 Nov 10, 2022	BUY	$24.1 - $39.66 $154,673 - $254,537	6,418 Added 32.9%	25,928 $741,000
Q2 2022 Aug 12, 2022	BUY	$18.36 - $60.07 $10,391 - $33,999	566 Added 2.99%	19,510 $480,000
Q1 2022 May 16, 2022	BUY	$48.97 - $65.46 $78,205 - $104,539	1,597 Added 9.21%	18,944 $1.07 Million
Q4 2021 Feb 14, 2022	BUY	$53.3 - $75.84 $135,275 - $192,481	2,538 Added 17.14%	17,347 $1.08 Million
Q3 2021 Nov 12, 2021	BUY	$62.66 - $88.26 $148,316 - $208,911	2,367 Added 19.02%	14,809 $939,000
Q2 2021 Aug 16, 2021	SELL	$67.45 - $85.63 $70,620 - $89,654	-1,047 Reduced 7.76%	12,442 $1.03 Million
Q1 2021 May 14, 2021	SELL	$65.1 - $93.59 $1.45 Million - $2.08 Million	-22,264 Reduced 62.27%	13,489 $993,000
Q4 2020 Feb 12, 2021	BUY	$48.36 - $77.92 $516,533 - $832,263	10,681 Added 42.6%	35,753 $2.59 Million
Q3 2020 Nov 13, 2020	BUY	$36.14 - $51.99 $537,727 - $773,559	14,879 Added 145.97%	25,072 $1.2 Million
Q2 2020 Aug 12, 2020	BUY	$22.98 - $48.57 $234,235 - $495,074	10,193 New	10,193 $428,000
Q4 2019 Feb 12, 2020	SELL	$17.74 - $39.52 $484,639 - $1.08 Million	-27,319 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$18.8 - $27.82 $513,597 - $760,014	27,319 New	27,319 $592,000

Others Institutions Holding SWTX

# of Institutions

Shares Held

28.2M

Call Options Held

3.66M

Put Options Held

507K

View Full List

About SpringWorks Therapeutics, Inc.

Ticker SWTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,401,100
Market Cap $2.93B
Description
SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...

More about SWTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account